The hormones in dosage market in Madagascar, excluding contraceptives and antibiotics, stood at 2.1176 million USD in 2023. From 2013 to 2016, the market declined significantly, particularly in 2016 with a 10.37% drop. It showed mild recovery from 2017 onwards with variable growth, including a peak in 2021. The last five years saw a minor average decline with a CAGR of -0.33%. The most recent years showed slight decline, notably a 9.38% decrease in 2022, followed by a modest dip of 0.32% in 2023.
Future trends to watch for:
- The impact of new hormonal therapies and genetic advancements on market demand.
- Potential influence of healthcare accessibility improvements.
- Regulatory changes affecting market stability.
- Shifts in local healthcare priorities and economic conditions.
